Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%		$54.50
$37.28
▼
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Oklo Inc. stock logo
OKLO
Oklo
$38.25
-1.5%		$41.33
$34.38
▼
$193.84
$7.52B1.1810.42 million shs7.34 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+15.15%
Oklo Inc. stock logo
OKLO
Oklo
-1.44%-3.51%-13.52%-23.59%-70.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%		$54.50
$37.28
▼
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Oklo Inc. stock logo
OKLO
Oklo
$38.25
-1.5%		$41.33
$34.38
▼
$193.84
$7.52B1.1810.42 million shs7.34 million shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+15.15%
Oklo Inc. stock logo
OKLO
Oklo
-1.44%-3.51%-13.52%-23.59%-70.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
2.00
Hold$54.670.03% Upside
Oklo Inc. stock logo
OKLO
Oklo
2.57
Moderate Buy$83.26117.67% Upside

Current Analyst Ratings Breakdown

Latest AKRO and OKLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2026
Oklo Inc. stock logo
OKLO
Oklo
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$55.00
8/10/2026
Oklo Inc. stock logo
OKLO
Oklo
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$76.00 ➝ $57.50
8/10/2026
Oklo Inc. stock logo
OKLO
Oklo
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$55.00 ➝ $51.00
8/10/2026
Oklo Inc. stock logo
OKLO
Oklo
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$90.00
8/10/2026
Oklo Inc. stock logo
OKLO
Oklo
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$125.00 ➝ $100.00
8/7/2026
Oklo Inc. stock logo
OKLO
Oklo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/22/2026
Oklo Inc. stock logo
OKLO
Oklo
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$82.00 ➝ $76.00
7/13/2026
Oklo Inc. stock logo
OKLO
Oklo
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold$55.00
6/25/2026
Oklo Inc. stock logo
OKLO
Oklo
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral
(Data available from 9/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/A$10.75 per shareN/A
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/A$9.45 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$252.06M-$1.94N/AN/AN/AN/A-15.86%-14.78%N/A
Oklo Inc. stock logo
OKLO
Oklo
-$105.66M-$0.94N/AN/AN/AN/A-7.11%-6.92%11/10/2026 (Estimated)

Latest AKRO and OKLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
Oklo Inc. stock logo
OKLO
Oklo
-$0.1638-$0.28-$0.1162-$0.28$0.09 million$1.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/AN/A
Oklo Inc. stock logo
OKLO
Oklo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
15.84
15.83
Oklo Inc. stock logo
OKLO
Oklo
N/A
48.46
48.46

Institutional Ownership

CompanyInstitutional Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
Oklo Inc. stock logo
OKLO
Oklo
85.03%

Insider Ownership

CompanyInsider Ownership
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
7.07%
Oklo Inc. stock logo
OKLO
Oklo
12.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3082.32 million76.50 millionOptionable
Oklo Inc. stock logo
OKLO
Oklo
205186.02 million162.39 millionOptionable

Recent News About These Companies

The Math Doesn't Lie: What Oklo's Stock Sales Actually Cost Investors
 |  fool.comhttps://www.fool.com/investing/2026/09/25/the-math-doesnt-lie-what-oklos-stock-sales-actuall/
Oklo (NYSE:OKLO) Stock Price Down 1.5% - What's Next?
September 24 at 5:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-oklo-nyse-oklo-stock-price-down-15-whats-next-2026-09-24/
Oklo (NYSE:OKLO) Shares Down 4% - Here's Why
September 23 at 5:20 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-oklo-nyse-oklo-shares-down-4-heres-why-2026-09-23/
Nuclear Reactor Stocks Surge As Oklo (NYSE: OKLO), NuScale Power (NYSE: SMR), And Uranium Energy (NYSEAMERICAN: UEC) Recover From Last Week’s Policy-Trade Selloff
September 22 at 11:40 PM  |  foreignpolicyjournal.comF
Promising Nuclear Stocks To Consider - September 22nd
September 22 at 2:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-nuclear-stocks-to-consider-september-22nd-2026-09-22/
NuScale's E2 Centers Turn SMR Learning Into Hands-On Training
September 22 at 10:26 AM  |  zacks.comhttps://www.zacks.com/stock/news/2993759/nuscale-s-e2-centers-turn-smr-learning-into-hands-on-training?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-2993759
Oklo (NYSE: OKLO) Stock’s Fair Value Slashed 11% As Analysts Clash Over Execution Risk And Long-Term Growth
September 21, 2026  |  foreignpolicyjournal.comF
This Energy Stock Has 130% Upside Potential
September 21, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/09/21/oklo-stock-has-a-long-term-energy-story-unlike-almost-anything-else/
Oklo (NYSE:OKLO) Stock Price Up 5.6% - Here's What Happened
September 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-oklo-nyse-oklo-stock-price-up-56-heres-what-happened-2026-09-21/
Top Nuclear Stocks To Research - September 21st
September 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-top-nuclear-stocks-to-research-september-21st-2026-09-21/
This Energy Stock Has 130% Upside Potential
September 21, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/09/21/oklo-stock-has-a-long-term-energy-story-unlike-almost-anything-else/?utm_source=snapi
GE Vernova vs. Oklo: Which Industrials Stock Is a Better Buy in 2026?
September 21, 2026  |  fool.comhttps://www.fool.com/coverage/better-buy/2026/09/21/ge-vernova-vs-oklo-which-industrials-stock-is-a-better-buy-in-2026/
Oklo Climbs 5% as Nuclear Names Bounce Back From Last Week's Selloff; NuScale Power Gains 4%, Uranium Energy Rises 3%
September 21, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/09/21/oklo-climbs-5-as-nuclear-names-bounce-back-from-last-weeks-selloff-nuscale-power-gains-4-uranium-energy-rises-3/?utm_source=snapi
Nuclear Stocks To Add to Your Watchlist - September 18th
September 21, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036263
Nuclear Energy Boom Makes Oklo (NYSE: OKLO) And Cameco (NYSE: CCJ) Two Of The Smartest Buys In The Market
September 19, 2026  |  foreignpolicyjournal.comF
Oklo (OKLO) Stock Sees Fair Value Cut As Analysts Weigh Growth Against Execution Risk
September 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/oklo-oklo-stock-sees-fair-180828432.html
Got $1,000? 2 No-Brainer Nuclear Stocks to Buy Right Now.
September 19, 2026  |  fool.comhttps://www.fool.com/investing/2026/09/19/got-1000-2-no-brainer-nuclear-stocks-to-buy-right/
Oklo (NYSE:OKLO) Stock Price Down 4.1% - What's Next?
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-oklo-nyse-oklo-stock-price-down-41-whats-next-2026-09-18/
Oklo Stock Jumps 11% After Congress Acts on AI Power Costs
September 18, 2026  |  coincentral.comC
Oklo plans to deploy first Aurora microreactors by 2028
September 18, 2026  |  cryptobriefing.comC
Oklo (OKLO) Stock Surges 11% as House Passes Data Center Energy Bill
September 18, 2026  |  blockonomi.comhttps://blockonomi.com/oklo-oklo-stock-surges-11-as-house-passes-data-center-energy-bill/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akero Therapeutics stock logo

Akero Therapeutics NASDAQ:AKRO

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Oklo stock logo

Oklo NYSE:OKLO

$38.25 -0.57 (-1.46%)
Closing price 09/24/2026 03:59 PM Eastern
Extended Trading
$38.80 +0.55 (+1.45%)
As of 04:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas